Pulse News Wire translates Japanese corporate disclosures filed with the Tokyo Stock Exchange's TDNet system into clear, structured English for institutional investors, hedge funds, and asset managers. Every article on this page is derived directly from an official TDNet filing — including earnings reports, M&A announcements, share buybacks, dividend declarations, and governance changes. Japanese corporate governance is governed by the Companies Act and the Financial Instruments and Exchange Act; timely translation of these disclosures provides a material information advantage for cross-border investors monitoring Tokyo-listed equities.
This corporate disclosure from was processed by Pulse News Wire on February 10, 2026. It represents a primary source document for Japanese M&A sector intelligence, translated directly from an official filing submitted to the Tokyo Stock Exchange TDNet system.
Source disclosure: February 10, 2026 Matsuya R&D Co.,Ltd [7317.T] TOKYO — Matsuya R&D Co., Ltd. (Code: 7317, Tokyo Growth) announced on February 10, 2026, that it has recorded a special loss of 124 million yen related to an open tender offer from Omron Healthcare Co., Ltd. for its shares and subscription rights during the third quarter ending December 31, 2025. The company disclosed that as part of this tender offer, various advisory fees and legal expenses totaling 124 million yen